42470 Federal Register / Vol. 87, No. 135 / Friday, July 15, 2022 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (CDC) of the Statement of 

Organization, Functions, and 

Delegations of Authority of HHS (45 FR 

67772–76, dated October 14, 1980, and 

corrected at 45 FR 69296, October 20, 

1980, as amended most recently at 86 

35511–35520, dated July 6, 2021) is 

amended to reflect the reorganization of 

the National Center for Injury 

Prevention and Control (NCIPC), Deputy 

Director for Non-Infectious Diseases, 

CDC. This reorganization approved by 

the Director, CDC, on July 1, 2022, will 

streamline the current organizational 

structure, improve the overall 

employee/supervisor ratio, eliminate 

workflow inefficiencies, and improve 

customer service. 

I. Under Part C, Section C–B, 

Organization and Functions, make the 

following changes: 

• Update the functional statements 

for the Division of Violence Prevention 

(CUHC) 

• Update the functional statements 

for the Office of the Director (CUHC1) 

• Establish the Office of Policy, 

Partnerships, and Communication 

(CUHC12) 

• Establish the Office of Senior 

Director for Scientific Programs 

(CUHC13) 

• Establish the Office of the Associate 

Director for Science (CUHC13b) 

• Establish the Office of the Deputy 

Director for Management and Program 

Operations (CUHC14) 

• Establish the Office of Management 

and Operations (CUHC14b) 

• Update the functional statements 

for the Surveillance Branch (CUHCB) 

• Update the functional statements 

for the Research and Evaluation Branch 

(CUHCC) 

• Retitle the Prevention Practice and 

Translation Branch to the Violence 

Prevention Practice and Translation 

Branch (CUHCD) 

• Update the functional statements 

for the Field Epidemiology and 

Prevention Branch (CUHCE) 

• Establish the Community Violence 

Prevention Practice and Translation 

Branch (CUHCG) 

• Update the functional statements 

for the Division of Injury Prevention 

(CUHF) 

• Update the functional statements 

for the Office of the Director (CUHF1) 

• Establish the Office of Science 

(CUHF12) 

• Establish the Office of Policy and 

Partnerships (CUHF13) 

• Establish the Office of Management 

and Operations (CUHF14) 

• Establish the Office of 

Communications (CUHF15) 

• Update the functional statements 

for the Division of Overdose Prevention 

(CUHG) 

• Update the functional statements 

for the Office of the Director (CUHG1) 

• Establish the Office of Policy, 

Planning, and Partnerships (CUHG12) 

• Establish the Office of the Associate 

Director for Program Implementation 

(CUHG13) 

• Establish the Office of the Deputy 

Director for Scientific Programs 

(CUHG14) 

• Establish the Office of the Associate 

Director for Science (CUHG14b) 

• Establish the Office of the Associate 

Director for Management Operations 

(CUHG15) 

• Establish the Office of Management 

and Operations (CUHG15b) 

• Update the functional statements 

for the Epidemiology and Surveillance 

Branch (CUHGB) 

• Update the functional statements 

for the Health Systems and Research 

Branch (CUHGC) 

• Update the functional statements 

for the Prevention Programs and 

Evaluation Branch (CUHGD) 

• Update the functional statements 

for the Drug-Free Communities Branch 

(CUHGE) 

• Update the functional statements 

for the Communications Branch 

(CUHGG) 

• Establish the State Program 

Implementation Branch (CUHGH) 

II. Under Part C, Section C–B, 

Organization and Functions, insert the 

following: 

• Division of Violence Prevention 

(CUHC). (1) Provides leadership in 

developing and executing a national 

program for the prevention and control 

of violence and its consequences; (2) 

plans, establishes, and evaluates 

surveillance systems to monitor national 

trends in morbidity, mortality, 

disabilities, health equity, and cost of 

violence-related injuries and deaths, 

and facilitates the development of 

surveillance systems by state, tribal, 

local, and territorial agencies; (3) plans, 

directs, conducts, and supports research 

focused on the causes of and health 

inequities in violence and the 

development and evaluation of 

strategies to prevent and control 

violence-related injuries and deaths; (4) 

produces new, evidence-based scientific 

knowledge that informs policies, 

practice, and programs in the violence 

field; (5) plans, conducts, supports, and 

evaluates demonstration projects and 

programs to prevent and control 

violence; (6) develops and disseminates 

policies, recommendations, and 

guidelines for the prevention of violence 

and its consequences; (7) proposes goals 

and objectives for linking health system 

and violence control activities with 

public health activities, including 

surveillance, prevention, healthcare, 

and rehabilitation of injury; (8) proposes 

goals and objectives for national 

violence prevention and control 

programs, monitors progress toward 

these goals and objectives, and 

recommends and develops guidelines 

for priority prevention and control 

activities; (9) provides expertise in 

public health practice, health equity, 

surveillance, evaluation, and research 

for violence prevention; (10) provides 

technical assistance, consultation, 

training, and epidemiological, 

statistical, educational, and other 

technical services to assist state and 

local health departments and 

community based organizations in the 

planning, development, 

implementation, evaluation, and overall 

improvement of violence prevention 

programs; (11) facilitates the 

development and supports the 

dissemination of research findings and 

transfer of violence prevention and 

control technologies to federal, state, 

and local agencies, private 

organizations, and other national and 

international groups; (12) sustains a 

public health infrastructure for violence 

prevention at federal, state, tribal, local, 

and territorial levels; (13) facilitates 

similar strategic planning activities by 

other federal, state, and local agencies, 

academic institutions, and private and 

other public organizations; and (14) in 

carrying out the above functions 

collaborates with other divisions of 

NCIPC, CDC Centers, Institute, and 

Offices (CIOs), HHS agencies, other 

federal, state, and local departments and 

agencies, academic institutions, private 

sector, voluntary, and international 

organizations, as appropriate. 

• Office of the Director (CUHC1). (1) 

Provides leadership and direction for 

division priorities and activities to 

monitor, prevent and reduce violent 

behavior and violence-related injuries 

and deaths; (2) leads the division to 

monitor trends in violent behavior and 

violence-related injuries and deaths and 

scales up prevention activities to reduce 

violence, risk factors, and consequences; 

(3) promotes strategies to achieve the 

vision of a violence-free society in 

which all people and communities are 

safe, healthy, and thriving; (4) plans, 

directs, coordinates, and evaluates the 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 135 / Friday, July 15, 2022 / Notices 42471 

activities of the division; (5) establishes 

and interprets policies, and determines 

program priorities; (6) provides national 

leadership and guidance in violence 

prevention and control program 

planning, development, and evaluation; 

(7) advances health equity in violence 

prevention through both research and 

programmatic activities; and (8) assures 

multi-disciplinary collaboration in 

violence prevention and control 

activities. 

• Office of Policy, Partnerships, and 

Communication (CUHC12). (1) Provides 

leadership and guidance to division 

management and staff on policies, 

planning and communications for 

violence prevention activities; (2) 

prepares, tracks, and coordinates 

controlled and general correspondence; 

(3) prepares responses and coordinates 

provision of materials requested by CDC 

leadership, Congress, HHS, other federal 

agencies, and non-governmental 

agencies; (4) coordinates with NCIPC 

Office of Policy and Partnerships to 

execute and support NCIPC- and CDCwide policy and partner-related 

initiatives related to violence 

prevention; (5) coordinates with the 

NCIPC Office of Communications to 

execute and support NCIPC- and CDCwide communication initiatives and 

policies; (6) develops tailored messages 

and materials to promote dissemination 

of scientific findings, evidence-based 

prevention strategies, priority 

recommendations, and guidelines 

through traditional media outlets, social 

media, and other channels; 

(7) collaborates with subject matter 

experts, program and policy staff, 

develops and implements 

communication strategies, campaigns, 

and plans to meet the needs of division 

programs and NCIPC’s mission, to 

provide leadership in preventing and 

controlling injuries by reducing the 

incidence, severity, and adverse 

outcomes of injury; (8) provides 

consultation on international violence 

prevention and control activities of the 

division; and (9) establishes linkages 

and collaborates, as appropriate, with 

other divisions and offices in NCIPC, 

with other CIOs throughout CDC, 

nongovernmental organizations; and 

with national level prevention partners 

that impact violence prevention 

programs. 

• Office of the Senior Director for 

Scientific Programs (CUHC13). (1) 

Directs and evaluates the cross-cutting 

scientific activities of the division; (2) 

provides leadership and guidance in 

scientific program planning, 

development, implementation, and 

evaluation for violence prevention 

activities; (3) coordinates division 

public health science efforts to protect 

the public’s health; (4) facilitates the 

translation of scientific knowledge into 

preventive actions; (5) ensures use of 

best practices to collect, analyze, and 

interpret data and disseminates 

scientific information to enable internal 

and external partners to make actionable 

decisions; and (6) integrates science, 

data analytics, and visualization into 

science products. 

• Office of the Associate Director for 

Science (CUHC13b). (1) Provides 

scientific leadership, planning, and 

guidance to division management and 

staff on research methodology and 

priorities for violence prevention 

research activities; 

(2) promotes DVP-funded science 

programs and activities, and advocates 

for science within the organization; (3) 

provides leadership on science policy 

development and implementation; (4) 

oversees scientific clearance and related 

quality assurance; (5) provides 

representation on scientific issues, 

internally within CDC and externally 

with partners; (6) contributes to the 

development of new scientific advances 

by preparing manuscripts for 

publication in scientific and technical 

journals and publications, including 

articles and guidelines published in the 

Morbidity and Mortality Weekly Report 

(MMWR) and other publications for the 

public; (7) supports scientific training 

opportunities and mentorship to 

scientists and fellows; and (8) in 

coordination with the NCIPC OS, 

reviews and approves surveillance, 

programmatic, and research project 

concepts, and ensures their compliance 

with federal regulations. 

• Office of the Deputy Director for 

Management and Program Operations 

(CUHC14). (1) Plans, directs, and 

evaluates the management and program 

operations activities of the division; (2) 

provides cross-cutting leadership and 

guidance in program planning, 

development, implementation, and 

evaluation for violence prevention 

activities; (3) oversees overarching 

personnel, operational, administrative, 

fiscal, and technical support for division 

programs and units; (4) provides 

leadership for and assessment of all 

administrative management activities of 

the division; (5) provides overall 

programmatic direction for planning 

and management oversight of allocated 

resources, human resource management 

and general administrative support for 

division programs and units; and 

(6) reviews the effectiveness and 

efficiency of all administration and 

operations of division programs and 

units. 

• Office of Management and 

Operations (CUHC14b). (1) Provides 

leadership, planning, and guidance to 

division management and staff on 

management and operations for violence 

prevention activities; (2) manages the 

budget through planning, execution, 

and closeout to facilitate daily 

operations; (3) provides over-arching 

personnel, operational, administrative, 

fiscal, and technical support for division 

programs and units; (4) develops and 

implements processes to provide 

efficiency in facilitating work to prevent 

violent behavior and violence-related 

injuries and deaths; (5) carries out 

routine office functions and meets 

administrative requirements necessary 

for daily functions; and (6) coordinates 

and oversees the implementation of 

available assistance mechanisms to 

prevent violent behavior and violencerelated injuries and deaths. 

• Surveillance Branch (CUHCB). (1) 

Advises the Office of the Director, in 

DVP and NCIPC, on all aspects of 

violence surveillance including data 

and systems management by providing 

data to inform violence program 

planning; 

(2) conducts national, state, and local 

surveillance and surveys to identify new 

and monitor recognized forms of 

violence and its consequences, analyzes 

and interprets data, examines patterns 

in health equity (e.g., by race/ethnicity, 

gender, gender identity, sexual 

orientation, and disability), and 

monitors trends in violence and its 

trajectory across the lifespan; (3) 

consults and collaborates with other 

branches to promote using surveillance 

data to inform preventive actions; (4) 

coordinates, manages, maintains, and 

provides tabulations and maps from 

surveillance systems and other data 

sources that contain national, state, and 

local data on violence-related morbidity, 

mortality, and economic costs; (5) 

develops and implements uniform 

definitions for public health 

surveillance of various forms of violence 

and related outcomes; (6) provides 

leadership for the development of 

surveillance systems to inform policies, 

practice, and programs in the violence 

prevention field; (7) provides expert 

consultation to federal, state, and local 

health agencies on surveillance system 

design, implementation, and evaluation, 

and use of surveillance data to describe 

the burden of violence; (8) disseminates 

violence surveillance information to the 

scientific community and the general 

public through regular publication in 

peer-reviewed journals and CDC 

publications, presentations at 

professional conferences and other 

partner group meetings, and through a 


jspears on DSK121TN23PROD with NOTICES1
42472 Federal Register / Vol. 87, No. 135 / Friday, July 15, 2022 / Notices 

public-facing dashboard; (9) develops, 

designs, implements, and evaluates 

innovative surveillance strategies to 

address gaps and apply surveillance 

data to epidemiological studies, 

program evaluation, and programmatic 

activities; and (10) in carrying out the 

above functions, provides leadership 

and collaborates with other divisions 

and offices in NCIPC, other CIOs 

throughout CDC, and other federal, 

state, and local departments and 

agencies, academic institutions, private 

sector, voluntary, and international 

organizations, as appropriate in all 

aspects of surveillance of violence and 

its consequences. 

• Research and Evaluation Branch 

(CUHCC). (1) Plans, directs, conducts, 

and supports formative, etiologic, and 

epidemiologic research focused on 

causal factors, risk and protective 

factors, and psychosocial, cultural, and 

contextual determinants for violence 

and its consequences; (2) plans, directs, 

conducts, and supports applied research 

focused on the rigorous evaluation of 

strategies, policies, and interventions to 

prevent violent behavior and violencerelated injuries and deaths; (3) evaluates 

the effectiveness and impact of violence 

prevention strategies, policies, and 

interventions as practiced or 

implemented by public health agencies 

and organizations at the national/ 

regional and state/local levels; (4) 

conducts implementation research to 

examine the context, processes, and 

factors that influence effective and 

efficient dissemination/diffusion, 

uptake/adoption, implementation, 

translation, and sustainability of 

violence prevention strategies, policies, 

and interventions; (5) conducts research 

that promotes health equity by reducing 

the inequitable burden of risk for 

violence exposure experienced by racial 

and ethnic minority and other 

disproportionately affected (e.g., gender, 

sexual orientation, and disability) 

groups to better understand risk and 

protective factors contributing to these 

inequities and evaluate violence 

prevention strategies, policies, and 

interventions to remediate them; (6) 

develops and evaluates methodologies 

for conducting violence prevention 

research evaluation; (7) contributes to 

the research literature and evidence 

base by publishing regularly in peerreviewed journals, CDC sponsored 

publications and government reports 

that include, but are not limited to, 

etiological, evaluation, and 

implementation research and research 

syntheses; (8) serves as a resource, 

collaborates, and provides technical 

assistance in applying research and 

evaluation results and techniques to the 

ongoing assessment and improvement of 

violence prevention and control 

approaches; (9) disseminates research 

findings to help guide the development 

of prevention strategies, policies, and 

interventions or to improve the 

effectiveness of existing strategies, 

policies, and interventions to prevent 

and reduce violence, its risk factors, and 

its consequences; and (10) in carrying 

out the above functions, collaborates 

with other components within NCIPC, 

CDC, the Public Health Service, HHS, 

other federal agencies, and national and 

international professional, academic, 

voluntary, philanthropic organizations, 

and other entities. 

• Violence Prevention Practice and 

Translation Branch (CUHCD). (1) 

Provides leadership and support in 

public health practice and the 

application of science for maximum 

benefit of violence prevention 

programmatic efforts; (2) plans, directs, 

conducts, and supports program 

evaluation of strategies, policies, and 

programs to prevent violent behavior 

and violence-related injuries and 

deaths; (3) monitors and evaluates 

violence prevention programs and 

policies, and disseminates findings to 

promote program accountability and 

program improvement; (4) promotes an 

enhanced and sustained infrastructure 

for a public health approach to violence 

prevention at state, tribal, local, and 

territorial levels; (5) provides leadership 

and technical assistance in promoting 

health equity as an integral part of 

programmatic activities to prevent 

violence and in adapting evidencebased strategies to create the optimal 

conditions for health and safety for all 

communities and people regardless of 

race/ethnicity, sexual orientation, 

gender identity, poverty, geography, 

capacity, or religion. (6) generates and 

moves practice based knowledge into 

program practice and research fields; (7) 

develops and evaluates methodologies 

for conducting program evaluation; (8) 

identifies findings, lessons learned, and 

evidence from the field and collaborates 

with internal and external partners to 

inform research, surveillance, and 

program evaluation that builds the 

evidence base for effective violence 

prevention; (9) provides support, 

training, and technical assistance that 

applies sound prevention principles and 

systematic processes to enhance public 

health practice, including program 

development, implementation, 

improvement, and competence of 

personnel engaged in violence 

prevention and control research 

practices; (10) applies the best available 

evidence from translational science and 

continuous quality improvement to help 

communities select, adopt, adapt, 

implement, disseminate, sustain, and 

scale up programs, strategies, and 

activities that will lead to successful 

violence prevention outcomes; (11) 

works to reduce violence by supporting 

state and local violence prevention and 

control programs, and promoting the 

dissemination and application of 

science into program practice in the 

violence prevention field; (12) 

synthesizes relevant research, 

evaluation findings, evidence, and 

trends to develop practical guidance 

and resources that enhance violence 

prevention programs, strategies, and 

activities; (13) communicates internally 

and externally the important work and 

progress of the staff, recipients, and 

partners; (14) plans, conducts, supports, 

and evaluates demonstration projects 

and programs to prevent and control 

violence; (15) proposes goals and 

objectives for national violence 

prevention and control programs, 

monitors progress toward these goals 

and objectives, and recommends and 

develops guidelines for priority 

prevention and control activities; (16) 

provides national leadership and 

guidance in violence prevention and 

control program planning, development, 

and evaluation; (17) develops and 

manages liaison and collaborative 

relationships with professional, 

community, international, federal, and 

other agencies involved in violence 

prevention activities; and (18) in 

carrying out the above functions, 

provides leadership and collaborates 

with other divisions and offices in 

NCIPC, other CIOs throughout CDC, and 

other federal, state, local, nongovernmental, voluntary, professional, 

and international organizations in all 

aspects of public health practice as it 

relates to violence prevention. 

• Field Epidemiology and Prevention 

Branch (CUHCE). (1) Conducts 

investigations to address important 

public health problems related to 

violence; (2) conducts domestic and 

international surveys to assess 

incidence and prevalence of violence, 

risk factors, and health consequences, 

and monitors trends in violence and its 

trajectory across the lifespan; (3) collects 

data to inform the timely development 

of violence prevention initiatives; (4) 

builds capacity of public health to guide 

application of data to prevent violence; 

(5) conducts field epidemiology through 

field investigations and field support to 

improve collection of data on violence 

and provide timely recommendations 

on evidence-based violence prevention 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 135 / Friday, July 15, 2022 / Notices 42473 

interventions; (6) advances health 

equity and prevents violence globally 

and in the U.S. through data collection 

and application of evidence-based, datainformed violence prevention practices; 

(7) synthesizes and translates relevant 

research, evaluation findings, evidence, 

and trends, and ensures that 

communication and marketing 

technologies are applied to the 

development of practical tools, 

products, trainings, and guidance that 

enhance international violence 

prevention programs, strategies, and 

activities; (8) uses research findings to 

develop new or improve existing 

strategies, policies, and interventions to 

prevent and reduce violent behavior, its 

risk factors, and consequences; 

(9) disseminates scientific findings, 

evidence-based prevention strategies, 

and violence prevention guidelines 

through publication of research findings 

in professional journals and government 

reports, through participation in 

national and international meetings, 

seminars, and conferences, and through 

the development of communication 

initiatives; (10) establishes and sustains 

partnerships with other CDC CIOs and 

federal and non-government partners to 

improve the health and safety of youth 

by linking systematic measurement of 

violence with multi-sectoral, effective, 

scalable, and sustainable actions to 

reduce violence and its consequences; 

(11) works to reduce community 

violence by supporting state and local 

violence prevention and control 

programs and promote the 

dissemination and application of 

science into program practice in the 

violence prevention field; 

(12) synthesizes relevant research, 

evaluation findings, evidence, and 

trends to develop practical guidance 

and resources that enhance community 

violence prevention programs, 

strategies, and activities; (13) leverages 

and applies science-based information 

to help organizations and government 

agencies to use data to inform public 

health action to develop, evaluate, and 

improve programs and strategies to 

prevent violence-related injuries, health 

problems, and deaths; (14) provides 

expert consultation and technical 

assistance, consultation, training, and 

epidemiological, statistical, and other 

technical services to assist international 

and local health entities in the planning, 

implementation, application, 

evaluation, and overall improvement of 

violence monitoring and violence 

prevention programming; and (15) in 

carrying out the above functions, 

collaborates with other divisions and 

offices of NCIPC, CIOs, HHS agencies, 

other federal, state, and local 

departments and agencies, academic 

institutions, private sector, voluntary, 

and international organizations, as 

appropriate on all aspects of violence 

surveillance. 

• Community Violence Prevention 

Practice and Translation Branch 

(CUHCG). (1) Provides leadership and 

support in public health practice and 

the application of science for maximal 

benefit of community violence (CV) 

prevention programmatic efforts; (2) 

plans, directs, conducts, and supports 

program evaluation of strategies, 

policies, and interventions to prevent 

community violence and related injuries 

and deaths; (3) monitors and evaluates 

community violence prevention 

programs, and disseminates findings to 

promote program accountability and 

program improvement; (4) promotes an 

enhanced and sustained CV 

infrastructure for a comprehensive 

approach based on scaling up and/or 

implementing proven programs and 

policies to stem current violence and 

prevent future violence from occurring; 

(5) provides leadership and technical 

assistance in promoting health equity as 

an integral part of programmatic 

activities to prevent violence and in 

adapting evidence-based strategies to 

create the optimal conditions for health 

and safety for all communities and 

people regardless of race/ethnicity, 

sexual orientation, gender identity, 

poverty, geography, capacity, or 

religion; (6) generates and moves 

practice-based knowledge into program 

practice and research fields; (7) 

develops and evaluates methodologies 

for conducting program evaluation; (8) 

identifies findings, lessons learned, and 

evidence from the field and collaborates 

with internal and external partners to 

inform research, surveillance, and 

program evaluation that builds the 

evidence base for effective violence 

prevention; (9) provides support, 

training, and technical assistance that 

applies sound prevention principles and 

systematic processes to enhance public 

health practice, including program 

development, implementation, 

improvement, and competence of 

personnel engaged in community 

violence prevention practices; (10) 

applies the best available evidence from 

translational science and continuous 

quality improvement to help 

communities select, adopt, adapt, 

implement, disseminate, sustain, and 

scale up programs, strategies, and 

activities that will lead to successful 

community violence prevention 

outcomes; (11) communicates internally 

and externally the important work and 

progress of the staff, recipients, and 

partners; (12) plans, conducts, supports, 

and evaluates demonstration projects 

and programs to prevent and control 

community violence; (13) proposes 

goals and objectives for national 

community violence prevention 

programs, monitors progress toward 

these goals and objectives, and 

recommends and develops guidelines 

for priority prevention activities; (14) 

provides national leadership and 

guidance in community violence 

prevention program planning, 

development, and evaluation; (15) 

develops and manages liaison and 

collaborative relationships with other 

federal, state, and local departments and 

agencies, academic institutions, private 

sector, and voluntary organizations 

involved in community violence 

prevention activities; and (16) in 

carrying out the above functions, 

provides leadership and collaborates 

with other divisions and offices in 

NCIPC, other CIOs throughout CDC, and 

federal, state, local, non-governmental, 

voluntary, professional, and 

international organizations in all aspects 

of public health practice as it relates to 

community violence prevention. 

• Division of Injury Prevention 

(CUHF). (1) Integrates injury prevention 

strategies with healthcare delivery; (2) 

develops and disseminates policies, 

recommendations, and guidelines for 

the prevention of injury and its 

consequences; (3) develops and 

implements evidence-based public 

health practices, policies, or programs 

that prevent or reduce unintentional 

and self-directed injuries; (4) identifies 

findings, lessons learned, and potential 

best practices from the field and 

collaborates with internal and external 

partners to conduct scientific 

investigations to examine the context, 

processes, and factors that influence the 

risk of injuries and successful 

implementation of prevention strategies; 

(5) plans, establishes, and maintains 

surveillance systems to monitor national 

trends in morbidity, mortality, 

disabilities, and cost of injuries and 

facilitates the development of 

surveillance systems by state and local 

agencies; (6) produces and disseminates 

new scientific knowledge to inform 

policies, practice, and programs in the 

injury field; (7) supports the 

development and enhancement of state, 

tribal, local, and territorial injury 

prevention programs that integrate 

evidence-based population health 

strategies, surveillance, and evaluation 

in collaboration with other public 

health and non-public health sectors to 

promote injury control and prevention; 

(8) provides expertise in statistics, 


jspears on DSK121TN23PROD with NOTICES1
42474 Federal Register / Vol. 87, No. 135 / Friday, July 15, 2022 / Notices 

computer programming, data science, 

economics, public health practice, 

surveillance, evaluation, and research to 

engage NCIPC and the injury prevention 

community; (9) leads translation and 

dissemination of injury prevention and 

control research findings and injury 

data to federal, state, tribal, local, and 

territorial public health agencies, and 

public and private sector organizations 

with responsibilities and interests 

related to injury prevention; (10) 

supports the development and 

enhancement of public health 

infrastructure for injury prevention at 

federal, state, tribal, local, and territorial 

levels through funding, workforce 

training, and outreach; and (11) leads 

innovative data science activities to 

address injury data and information 

needs and inform research and 

prevention activities. 

• Office of the Director (CUHF1). (1) 

Provides leadership and direction for 

division priorities and activities to 

monitor, prevent, and reduce 

unintentional and self-directed injuries; 

(2) leads the division to monitor trends 

in the injury field and scales up 

prevention activities to reduce injury 

and its consequences; (3) promotes 

intervention strategies for injuries to 

advance NCIPC and CDC’s mission; (4) 

plans, directs, coordinates, and 

evaluates the activities of the division; 

(5) leads division strategic planning and 

priority setting and oversees overall 

program performance, scientific quality 

of activities, and operational policies to 

advance NCIPC and CDC’s mission; (6) 

provides leadership, representation, and 

consultation on cross-agency, intragovernmental, non-governmental, and 

international workgroups and forums to 

advance division goals and NCIPC and 

CDC’s mission; and (7) oversees the 

development of research to inform 

policies, practice, and programs in the 

injury field. 

• Office of Science (CUHF12). (1) 

Provides leadership, planning, and 

guidance to division management and 

staff on scientific policy, priorities, and 

research methodology for injury 

prevention and control practices; (2) 

ensures division programs and units 

produce the highest quality, most useful 

and relevant science possible; (3) leads 

development and updates to research 

priorities for injury prevention and 

control in collaboration with division 

programs and provides tools and 

assessment to ensure research informs 

policy, practice, and programs in the 

injury field; (4) prepares and monitors 

clearance of manuscripts for publication 

in scientific and technical journals and 

publications, including articles and 

guidelines published in the MMWR and 

other publications for the public; (5) 

supports scientific training 

opportunities and mentorship to 

scientists and fellows; and (6) provides 

leadership for the development of 

research to inform policies, practice, 

and programs in the injury field. 

• Office of Policy and Partnerships 

(CUHCF13). (1) Provides leadership and 

guidance to division management and 

staff on policies and partnership for 

injury prevention and control; (2) 

implements operational policies to 

advance NCIPC and CDC’s mission; (3) 

develops and manages collaborative 

relationships with professional, 

community, international, 

governmental, and non-governmental 

agencies, and tribal nations, to advance 

injury prevention and control; (4) 

coordinates with the NCIPC Office of 

Policy and Partnerships to identify and 

proactively manage emerging policy 

issues; (5) coordinates with the NCIPC 

Office of Policy and Partnerships and 

division staff to provide program, 

performance, and budgetary information 

related to the division’s activities for 

internal and external stakeholders and 

policy makers; (6) coordinates with 

division staff to prepare briefing 

materials; (7) collaborates with other 

NCIPC divisions and Offices and other 

CIOs throughout CDC on critical injury 

prevention programs; and (8) prepares, 

tracks, and coordinates responses to all 

inquiries from NCIPC leadership, 

Congress, HHS, other federal agencies, 

and non-governmental agencies. 

• Office of Management and 

Operations (CUHCF14). (1) Provides 

leadership, planning, and guidance to 

division management and staff on 

management and operations for injury 

prevention and control practices; (2) 

manages the budget through planning, 

execution, and closeout to facilitate 

daily operations; (3) provides overarching personnel, operational, 

administrative, fiscal, and technical 

support for division programs and units; 

(4) develops and implements processes 

to efficiently facilitate work on 

prevention and control injuries; (5) 

carries out routine office functions and 

meets administrative requirements 

necessary for daily functions; and (6) 

coordinates and oversees the 

implementation of available assistance 

mechanisms to prevent and control 

injuries. 

• Office of Communications 

(CUHCF15). (1) Provides leadership and 

guidance to division management and 

staff on communications initiatives and 

policies, including health literacy, plain 

language, and CDC branding for injury 

prevention and control topics and 

practices; (2) collaborates with subject 

matter experts and program and policy 

staff to develop strategic communication 

plans that meet division, NCIPC, and 

CDC priorities; (3) develops, 

implements, and evaluates 

communication strategies, campaigns, 

and materials to disseminate data and 

scientific findings, evidence-based 

prevention strategies, priority 

recommendations, programmatic 

successes, and guidelines through 

traditional and emerging 

communication channels; (4) facilitates 

coordination of cross-cutting topics 

related to effective communications 

strategies and ensures incorporation of 

lessons learned to promote 

communications best practices; (5) leads 

digital communication and marketing 

strategies and manages digital channels 

in the injury field; and (6) provides 

ongoing communication leadership, 

support, and strategic direction to 

division programs and units. 

• Division of Overdose Prevention 

(CUHG). (1) Plans, establishes, 

evaluates, uses, and collaborates on 

surveillance systems to monitor local, 

state, and national trends in morbidity, 

mortality, risk and protective factors 

related to drug use and overdose, and 

implements programmatic strategies to 

prevent drug use and overdose; (2) 

plans, directs, conducts, and supports 

research and advanced analytics 

focused on the causes, risks, and 

protective factors associated with drug 

use and overdose and identifies 

strategies at the federal, state, and local 

level, as well as in health systems, to 

prevent drug use and overdose; (3) 

evaluates the effectiveness and impact 

of drug use and overdose-related 

interventions, strategies, policies, and 

programs as practiced or implemented 

by public health agencies and 

organizations at the federal, state, 

territorial, and local levels, including 

health systems and law enforcement/ 

public safety; (4) identifies, develops, 

translates, implements, and evaluates 

programs and evidence-based clinical 

guidelines and informs policies to 

prevent drug use and overdose; (5) 

facilitates the translation, 

dissemination, and sustainability of 

practice- and research-tested findings 

into widespread local, state, and 

national public health and health 

system practice to prevent drug use and 

overdose; (6) develops, translates, 

implements, and evaluates evidencebased clinical prescribing guidelines to 

improve patient outcomes and prevent 

drug overdose; (7) provides technical 

assistance, consultation, training, and 

capacity building to federal, state, and 

local agencies, non-profit and 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 135 / Friday, July 15, 2022 / Notices 42475 

international organizations, professional 

associations, and medical providers to 

prevent drug use and overdoses; (8) 

establishes and maintains relationships 

across HHS, CDC, and NCIPC and its 

partners, including state, territorial, and 

local public health agencies, other 

federal agencies, the healthcare sector, 

professional organizations, and other 

constituents, including academic 

institutions and international 

organizations, that address drug use and 

overdose prevention; and (9) develops 

or is actively involved in the 

development of drug use and overdose 

prevention educational materials, 

training courses, tools, and other 

communication materials, as 

appropriate, based on identified needs 

of partners. 

• Office of the Director (CUHG1). (1) 

Provides leadership and direction on 

division priorities and activities to 

monitor, prevent, and reduce harms 

associated with drug use, misuse, and 

overdose; (2) leads the division in 

monitoring trends in the drug overdose 

crisis and other emerging drug threats 

and identifies and scales prevention 

activities to address the evolving drug 

overdose crisis; (3) promotes strategies 

to achieve the vision to end drug 

overdose and related harms; (4) plans, 

directs, and evaluates division 

activities; (5) provides cross-cutting 

leadership and guidance in policy 

formation and program planning, 

development, implementation and 

evaluation for drug use and overdose 

prevention; and (6) ensures multidisciplinary collaboration in drug use 

and overdose prevention activities. 

• Office of Policy, Planning, and 

Partnerships (CUHG12). (1) Provides 

leadership and guidance to division 

management and staff on policies, 

planning, and partnership related to 

activities to monitor, prevent, and 

reduce harms associated with drug use, 

misuse, and overdose; (2) prepares, 

tracks, and coordinates controlled and 

general correspondence; (3) prepares 

responses and coordinates provision of 

materials requested by NCIPC 

leadership, CDC leadership, HHS, 

Congress, and other federal partners; (4) 

coordinates with NCIPC’s Office of 

Policy and Partnerships to execute and 

support NCIPC- and CDC-wide policyand partner-related initiatives focused 

on overdose prevention; (5) collaborates, 

as appropriate, with non-governmental 

organizations, academic institutions, 

philanthropic foundations, and other 

domestic and international partners to 

achieve the division’s mission; (6) tracks 

and monitors annual appropriations 

process, working with NCIPC staff to 

draft annual budget justifications and 

performance narratives; (7) coordinates 

with division and NCIPC leadership to 

develop enterprise risk mitigation 

efforts related to division activities and 

monitor performance measures related 

to division, NCIPC, and CDC 

performance; and (8) coordinates and 

implements national prevention 

strategies, programs, and policies in 

collaboration with state and local public 

health departments, community-based 

organizations, and other branches, CIOs, 

and federal agencies. 

• Office of the Associate Director for 

Program Implementation (CUHG13). (1) 

Provides leadership, guidance, and 

technical assistance to division 

management and staff to strengthen 

implementation of overdose 

surveillance and prevention programs 

and initiatives; (2) identifies, 

implements, and coordinates technical 

assistance strategies and supports to 

enhance the implementation and 

evaluation of the division’s overdose 

surveillance and prevention strategies 

and programs; 

(3) fosters and promotes opportunities 

for cross-program learning and leverages 

program synergies to improve 

coordination, consistency, and 

efficiencies across the division’s 

programmatic efforts aimed at reducing 

overdoses; (4) collaborates with other 

offices, CIOs, and national partners to 

identify and execute opportunities that 

increase the scope, reach, and impact of 

the division’s overdose prevention 

strategies; (5) establishes and maintains 

relationships with national partners and 

other key stakeholders to strengthen 

technical assistance and enhance 

subject matter expertise; (6) provides 

cross-cutting leadership, expertise, and 

guidance to inform and execute on 

program planning, development, and 

implementation of efforts, strategies, 

and activities to combat the changing 

drug overdose epidemic; (7) leverages 

programmatic data and research 

findings to inform the development 

and/or implementation of strategies, 

policies, and interventions; and (8) 

develops tools and resources to support 

the implementation of the division’s 

overdose surveillance and prevention 

strategies and activities. 

• Office of the Deputy Director for 

Scientific Programs (CUHG14). (1) 

Plans, directs, and evaluates the crosscutting scientific activities of the 

division; (2) provides leadership and 

guidance on scientific program 

planning, development, 

implementation, and evaluation for drug 

use and overdose prevention; (3) 

coordinates division public health 

science efforts to protect the public’s 

health; (4) develops capacity within 

states, territories, and localities to 

integrate new and existing 

epidemiological and scientific 

principles into operational and 

programmatic expertise within division 

programs and units; (5) ensures use of 

best practices to collect, analyze, and 

interpret data and disseminate scientific 

information to enable internal and 

external partners to make actionable 

decisions; and (6) translates and 

integrates science, data analytics, and 

visualization into science products. 

• Office of the Associate Director for 

Science (CUHG14b). (1) Provides 

scientific leadership, planning, and 

guidance to division management and 

staff on scientific policy, research 

methodology, and strategic priorities for 

overdose prevention activities, ensuring 

the integrity of the division’s scientific 

work; (2) provides leadership to develop 

research on etiologic, epidemiologic, 

and behavioral aspects of drug use and 

overdose prevention; evaluate 

prevention activities; and coordinate 

division activities with others involved 

in related work across NCIPC, CDC, 

HHS, and other partners; (3) implements 

and guides policies and procedures 

related to data management, sharing and 

public access, human subjects research 

protections, Paperwork Reduction Act 

regulations, Federal Advisory 

Committee Act regulations, and 

scientific authorship and misconduct, 

ensuring work is performed in 

accordance with these policies and 

guidance; (4) oversees adjudication of 

issues related to science disputes, 

scientific ethics, and misconduct; (5) 

ensures the division’s work is grounded 

in science and recommendations are 

evidence-based; (6) conducts portfolio 

reviews of scientific and programmatic 

initiatives in the division to identify 

critical gaps and opportunities for the 

future direction of research and 

programmatic work; (7) coordinates 

agency-wide and cross-agency cannabisrelated surveillance, research activities, 

and communications activities, and 

provides technical assistance for 

cannabis-related programmatic 

activities; (8) reviews and approves 

surveillance, programmatic, and 

research project concepts in 

coordination with NCIPC OS to ensure 

alignment with strategic priorities and 

compliance with federal regulations; (9) 

oversees and conducts clearance 

(scientific information product reviews) 

of manuscripts for publication in 

scientific and technical journals and 

publications, including articles and 

guidelines published in the MMWR, 

informational web content, and other 

publications for the public; (10) 


jspears on DSK121TN23PROD with NOTICES1
42476 Federal Register / Vol. 87, No. 135 / Friday, July 15, 2022 / Notices 

addresses critical research gaps through 

the development of extramural research 

funding opportunities and collaborates 

with the Extramural Research Program 

Office to ensure timely publication of 

funding opportunities and rigorous peer 

review of funding applications; and (11) 

supports scientific training 

opportunities and development of the 

scientific workforce, including the 

Epidemic Intelligence Service and Oak 

Ridge Institute for Science and 

Education training programs. 

• Office of the Associate Director for 

Management and Operations (CUHG15). 

(1) Plans, directs, and evaluates the 

management and operations activities of 

the division; (2) oversees over-arching 

personnel, operational, administrative, 

fiscal, and technical support for the 

division; (3) provides leadership for and 

assessment of all administrative 

management activities of the division; 

(4) provides overall direction for 

planning and management oversight of 

allocated resources, human resource 

management, and general administrative 

support for the division; and (5) reviews 

the effectiveness and efficiency of all 

administration and operations of the 

division. 

• Office of Management and 

Operations (CUHG15b). (1) Provides 

leadership, planning, and guidance to 

division management and staff on 

financial and administrative operations 

for overdose activities; (2) manages the 

budget through planning, execution, 

and closeout to facilitate daily 

operations; (3) provides expert 

consultation on personnel, operational, 

administrative, fiscal, and technical 

support management; (4) develops tools 

and implements processes to provide 

efficiency in facilitating work to reduce 

drug use and prevent overdose; (5) 

carries out over-arching, routine 

administrative requirements necessary 

for daily functions; (6) coordinates and 

oversees the implementation of 

available assistance mechanisms to 

prevent drug use and overdose; and (7) 

ensures proposed and ongoing 

operations are consistent with policy, 

practices, and procedures. 

• Epidemiology and Surveillance 

Branch (CUHGB). (1) Plans, establishes, 

and evaluates surveillance systems to 

monitor national, state, and local trends 

in nonfatal and fatal overdoses and 

innovative surveillance projects, such as 

biosurveillance, illicit drug supply 

monitoring, linkage to care tracking, and 

overdose data linkages; (2) develops and 

implements uniform definitions of 

various overdose-related outcomes for 

public health surveillance; (3) routinely 

disseminates surveillance data through 

publications, data briefs and reports, 

presentations, and CDC websites and 

data dashboards on national, state, and 

local trends on overdose-related 

outcomes and disparities, which 

includes the mapping of geographic 

variations; (4) monitors and tracks 

overdoses with surveillance systems to 

inform prevention programs at the state 

and local level; (5) develops, designs, 

implements, and evaluates innovative 

surveillance strategies or systems in 

collaboration with colleagues to address 

gaps in existing CDC surveillance 

systems that inform evaluation and 

programmatic activities; (6) plans and 

directs strategies to collect, analyze, and 

interpret scientific findings from 

surveillance and epidemiologic 

activities to evaluating trends, set 

priorities, and develop intervention 

strategies for overdose prevention; (7) 

develops comprehensive data 

management processes to manage 

overdose morbidity, mortality, and 

innovative surveillance data received 

through cooperative agreements and 

contracts; (8) plans and collaborates on 

data modernization and data science 

efforts with colleagues in NCIPC and 

other CIOs; (9) serve as subject matter 

experts providing technical assistance 

on surveillance activities with state and 

local entities; (10) plans and conducts 

data projects from data sources, such as 

toxicology data, to fill gaps in 

surveillance and investigates emerging 

and novel drug overdose threats; and 

(11) supports training to increase the 

number and capacity of personnel 

engaged in overdose epidemiology and 

surveillance—including supporting 

medical examiners/coroners in 

investigating drug overdose deaths. 

• Health Systems and Research 

Branch (CUHGC). (1) Supports applied 

research, advanced analytics, 

evaluation, and demonstration projects 

to determine the effectiveness of health 

system prevention interventions; 

enhance the impact of health systems; 

and expand the understanding of how to 

best integrate health systems with 

public health prevention efforts to 

prevent drug use and overdose; (2) 

develops, implements, and evaluates 

evidence-based clinical prescribing 

guidelines and accompanying 

translation materials to improve patient 

outcomes and prevent drug overdose; 

(3) conducts advanced overdose and 

treatment analytics and modeling to 

inform prevention strategies and 

provide jurisdictions and partners with 

actionable data and tools; (4) provides 

expert consultation to federal, state, 

local, and international health and 

public health agencies on applied 

research, evaluation, and health system 

implementation strategies; (5) provides 

scientific technical assistance to states, 

tribes, localities, and territories through 

programmatic efforts to increase their 

capacity to develop, implement, and 

evaluate system-level overdose 

prevention strategies; (6) develops, 

implements, and evaluates tools and 

resources to use in electronic health 

records and health IT systems to address 

overdoses and support data integration 

across data systems; (7) expands reach 

and scale of evidence-based health 

system interventions through strategic 

partnerships and collaboration with 

health systems and state, tribal, local, 

and territorial public health 

departments; (8) publishes regularly in 

peer-reviewed journals and CDCsponsored publications on topics that 

include, but are not limited to, 

programmatic, advanced analytics, 

modeling, evaluation, health systems, or 

community-based strategies to 

contribute to the research literature; and 

(9) supports dissemination of research, 

advanced analytics, evaluation, 

translation, and program 

implementation to federal, state, tribal, 

local, and territorial health agencies, 

public and private sector organizations, 

and other national and international 

groups with responsibilities and 

interests related to overdose prevention. 

• Prevention Programs and 

Evaluation Branch (CUHGD). (1) 

Provides programmatic leadership and 

support for drug use and overdose 

prevention activities in state, tribal, 

local, and territorial jurisdictions; (2) 

provides technical assistance and 

project officer support to grantees on 

evaluation and implementation of 

evidence- and practice-based 

interventions with the greatest reach 

and impact in state, tribal, local and 

territorial jurisdictions, including 

sustaining and scaling up programs, 

strategies, and activities over time in 

collaboration with public safety/law 

enforcement and other partners; (3) 

stimulates adoption and effective use of 

evidence-based strategies to prevent 

drug use and overdose, including 

addressing disproportionately affected 

populations; (4) collaborates with 

localities to develop, adapt, and adopt 

novel evidence-based strategies; (5) 

leverages epidemiology and surveillance 

data about drug overdose morbidity, 

mortality, and risk and protective 

factors to inform, tailor, and update 

prevention strategies across the life 

course; (6) monitors and evaluates the 

outcomes of division investments in 

state, tribal, local and territorial 

jurisdictions through program 

evaluation and applied prevention 


jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 135 / Friday, July 15, 2022 / Notices 42477 

science while widely disseminating 

findings to improve programmatic 

activities; (7) publishes the findings of 

programmatic evaluations in peerreviewed literature and other reports 

and participates in scientific and 

professional conferences; (8) serves as a 

resource, collaborates, and provides 

comprehensive technical assistance and 

training to state, tribal, local and 

territorial jurisdictions and other 

partners to reduce drug use and 

overdose; (9) synthesizes relevant 

research, evaluation findings, evidence, 

and trends to develop practical 

guidance and resources that enhance 

overdose prevention programs, 

strategies, and activities; (10) uses 

research findings to develop or improve 

strategies, policies, and interventions to 

prevent and reduce overdose, and its 

risk factors and consequences; and (11) 

collaborates with state, tribal, local, and 

territorial jurisdictions, public safety/ 

law enforcement, and other partners to 

use data to drive decision-making and 

action. 

• Drug-Free Communities Branch 

(CUHGE). (1) Provides programmatic 

leadership and support to communities/ 

localities and community coalitions 

under the Drug-Free Communities (DFC) 

Support and the Comprehensive 

Addiction and Recovery Act Local Drug 

Crisis (CARA Local Drug Crisis) Grant 

Programs; (2) provides comprehensive 

technical assistance and project officer 

support to the grant award recipients 

and serves as a resource and 

collaborator to implement communitybased youth substance use prevention 

interventions capable of effecting and 

sustaining community-level change and 

addressing local youth opioid, 

methamphetamine, and/or prescription 

medication abuse; (3) works with the 

grant award recipients to promote the 

seven Strategies for Community-Level 

Change (Provide Information, Enhance 

Skills, Provide Support, Enhance Access 

or Reduce Barriers, Change 

Consequences, Change Physical Design, 

Modify/Change Policies); (4) 

collaborates with staff across the 

division, NCIPC, and CDC to maximize 

opportunities and the subject matter 

expertise available for the 

implementation of the DFC Support and 

CARA Local Drug Crisis Grant 

Programs; (5) monitors and evaluates 

the outcomes of division investments in 

communities/localities and community 

coalitions in concert with the White 

House Office of National Drug Control 

Policy using rigorous evaluation 

methods and widely disseminating 

findings to improve future 

programmatic activities; (6) synthesizes 

relevant research, evaluation findings, 

evidence, and trends to develop 

practical guidance and resources that 

enhance community-based youth 

substance use prevention programs, 

strategies, and activities and present this 

work at relevant scientific and 

professional conferences; (7) uses 

research findings to develop new 

strategies and interventions or to 

improve the impact of existing strategies 

and interventions to prevent and reduce 

youth substance use and associated risk 

factors and consequences; and (8) 

provides assistance, as needed, to 

communities/localities and community 

coalitions to prevent youth substance 

use. 

• Communications Branch (CUHGG). 

(1) Oversees communication and 

marketing science, research, practice, 

and public affairs and ensures division 

materials meet HHS and CDC standards; 

(2) leads division’s strategic planning 

for communication, marketing science, 

and public affairs programs and projects 

and analyzes context, situation, and 

environment to inform division-wide 

communication and marketing programs 

and projects; (3) ensures use of 

scientifically-sound research for 

marketing and communication programs 

and projects and accurate, accessible, 

timely, and effective translation of 

science for the use of multiple 

audiences; (4) leads identification and 

implementation of information 

dissemination channels and provides 

communication and marketing project 

management expertise; (5) collaborates 

with external organizations, including 

media organizations, to ensure that 

scientific findings and their 

implications for public health reach the 

intended audiences; (6) collaborates 

closely with divisions to produce 

materials tailored to meet the 

requirements of news and other media 

channels, including press releases, 

letters to the editor, public service 

announcements, television 

programming, video news releases, and 

other electronic and printed materials; 

(7) coordinates the development and 

maintenance of accessible public 

information through the internet, social 

media, and other applicable channels; 

(8) provides training and technical 

assistance in health communication, 

risk communication, social marketing, 

and public affairs; (9) manages or 

coordinates communication services 

such as internet/intranet, application 

development, social media, video 

production, graphics, photography, CDC 

name and logo use, and other brand 

management; (10) plans, develops, 

conducts, and evaluates cross-cutting 

communication projects and campaigns 

to inform the media, health 

professionals, the public, and others 

about drug use and overdose 

prevention; (11) develops and evaluates 

messages, materials, and health 

communication products to promote 

and disseminate scientific findings, 

evidence-based prevention strategies, 

priority recommendations, and 

guidelines through various platforms; 

(12) provides editorial services, 

including writing, editing, and technical 

editing; (13) facilitates internal 

communication to NCIPC staff and 

allied audiences; (14) serves as a liaison 

to internal and external groups to 

advance the division’s mission and 

collaborates with NCIPC’s Office of 

Communication and CDC’s Office of the 

Associate Director for Communication 

on media relations, electronic 

communication, health media 

production, and brand management 

activities; (15) collaborates with the 

Center for Preparedness and Response 

and other CDC and the Agency for Toxic 

Substances and Disease Registry entities 

to fulfill communication responsibilities 

in emergency response situations; and 

(16) collaborates with other CDC CIOs to 

develop marketing communications 

targeted to populations that benefit from 

a cross-functional approach. 

• State Program Implementation 

Branch (CUHGH). (1) Provides 

programmatic leadership, guidance, and 

technical assistance to state health 

departments on a range of surveillance 

and prevention strategies to reduce and 

prevent drug overdoses; (2) provides 

programmatic and scientific support to 

strengthen state award recipients 

capacity to implement surveillance and 

prevention interventions capable of 

effecting and sustaining state-level 

change to combat drug overdoses; (3) 

coordinates with staff across the 

division, NCIPC, and CDC to leverage 

subject matter expertise and 

opportunities for collaboration to 

enhance development, implementation, 

and evaluation of overdose surveillance 

and prevention strategies needed to 

combat the changing drug overdose 

epidemic; (4) monitors and evaluates 

the outcomes of the division’s 

programmatic investments; (5) uses 

research findings to inform or improve 

strategies, policies, and interventions on 

surveillance and prevention strategies to 

combat drug overdoses through states 

and partners; and (6) synthesizes 

relevant research, evaluation findings, 

and trends to develop practical 

guidance and resources that enhance 

and expand state overdose prevention 

strategies and activities. 


jspears on DSK121TN23PROD with NOTICES1
42478 Federal Register / Vol. 87, No. 135 / Friday, July 15, 2022 / Notices 

III. Delegations of Authority: All 

delegations and redelegations of 

authority made to officials and 

employees of affected organizational 

components will continue pending 

further redelegation, provided they are 

consistent with this reorganization. 

(Authority: 44 U.S.C. 3101) 

Robin D. Bailey Jr., 

Chief Operating Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2022–15153 Filed 7–14–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 87 FR 36133, dated 

June 15, 2022) is amended to reflect the 

reorganization of the staff offices within 

the Office of the Director, Centers for 

Disease Control and Prevention (CDC). 

This reorganization approved by the 

Director, CDC, on July 5, 2022, will 

streamline the current organizational 

structure, improve the overall 

employee/supervisor ratio, eliminate 

workflow inefficiencies, and improve 

customer service. 

I. Under Part C, Section C–B, 

Organization and Functions, the 

following organizational units are 

deleted in its entirety: 

• Population Health and Healthcare 

Office (CAQE) 

• Public Private Partnerships Activity 

(CAT14) 

• Office of Communication Science 

(CAU13) 

• Division of Public Affairs (CAUB) 

• Office of the Director (CAUB1) 

• Digital Media Branch (CAUBB) 

• News Media Branch (CAUBC) 

• External and Employee Relations 

Branch (CAUBD) 

• Division of Communication Services 

(CAUD) 

• Office of the Director (CAUD1) 

• Broadcast Services Branch (CAUDB) 

• Graphics Services Branch (CAUDC) 

• CDC–INFO and Print Services Branch 

(CAUDD) 

• Minority Health and Health Equity 

(CBE12) 

• Diversity and Inclusion Management 

Program (CBEC) 

II. Under Part C, Section C–B, 

Organization and Functions, make the 

following change: 

• Update the functional statement for 

the CDC Washington Office (CAB) 

• Establish the Office of the Associate 

Director for Global Health Diplomacy 

and Strategy (CAE) 

• Establish the Office of the Director 

(CAE1) 

• Establish the Division of Diplomacy, 

Policy, and External Partner 

Engagement (CAEB) 

• Establish the Division of Global 

Health Strategic Planning and 

Coordination (CAEC) 

• Establish the Division of Regional 

Engagement and Coordination (CAED) 

• Update the functional statement for 

the Strategic Business Initiatives Unit 

(CAJ13) 

• Retitle the Policy, Research, Analysis, 

and Development Office to the Office 

of Policy Analytics and Population 

Health (CAQB) 

• Update the functional statement for 

the Office of the Chief of Staff (CAT) 

• Update the functional statement for 

the Office of the Director (CAT1) 

• Retitle the Meeting and Advance 

Team Management Activity to the 

Advance Team Activity (CAT12) 

• Update the functional statement for 

the Budget and Operations 

Management Activity (CAT13) 

• Establish the Policy, Performance, and 

Communications Activity (CAT16) 

• Retitle the Division of Issues 

Management, Analysis and 

Coordination (CATC) to the Office of 

the Executive Secretariat (CATC) 

• Update the functional statements for 

the Office of the Associate Director for 

Communication (CAU) 

• Update the functional statement for 

the Office of the Director (CAU1) 

• Establish the Office of Internal 

Communication and Engagement 

(CAU14) 

• Establish the Office of External 

Engagement (CAU15) 

• Establish the Office of Management 

and Operations (CAU16) 

• Establish the Division of 

Communication Science and Services 

(CAUE) 

• Establish the Office of the Director 

(CAUE1) 

• Establish the Communication Science 

Branch (CAUEB) 

• Establish the Communication Support 

and Services Branch (CAUEC) 

• Establish the Division of Digital 

Media (CAUG) 

• Establish the Office of the Director 

(CAUG1) 

• Establish the Enterprise Technology 

Branch (CAUGB) 

• Establish the Visual Design Branch 

(CAUGC) 

• Establish the Content and Engagement 

Branch (CAUGD) 

• Establish the Division of Media 

Relations (CAUH) 

• Establish the Office of the Director 

(CAUH1) 

• Establish the Media Support Branch 

(CAUHB) 

• Establish the Broadcast and 

Multimedia Branch (CAUHC) 

• Retitle the Office of Equal 

Employment Opportunity to the 

Office of Equal Employment 

Opportunity and Workplace Equity 

(CAV) 

• Establish the Minority Health and 

Health Equity Program (CBED) 

II. Under Part C, Section C–B, 

Organization and Functions, insert the 

following: 

• CDC Washington Office (CAB). 

Directs and manages CDC interactions 

with Congress; (2) develops and 

executes legislative strategies; (3) 

collaborates with the Office of the Chief 

Operating Officer to develop and 

execute strategies in Congress that 

advance CDC appropriations priorities; 

(4) builds congressional relationships; 

(5) tracks and analyzes legislation; (6) 

develops strategy and leads response to 

congressional, Government 

Accountability Office (GAO), and Office 

of Inspector General (OIG) oversight; (7) 

builds relationships with government 

agencies and other organizations to 

advance agency priorities, with an 

emphasis on federal agencies; (8) 

protects and advances the agency’s 

reputation, scientific credibility, and 

interests; (9) informs CDC leadership of 

current developments and provides 

insight into the Washington policy 

environment; (10) coordinates DC-area 

assignees and helps maximize their 

impact in supporting the agency’s 

strategies and priorities; and (11) 

coordinates CDC’s partnership activities 

as they relate to Washington-based, or 

Washington-focused organizations, and 

works across the agency to advance 

those relationships. 

• Office of the Associate Director for 

Global Health Diplomacy and Strategy 

(CAE). The mission of the Office of the 

Associate Director for Global Health 

Diplomacy and Strategy is to advise and 

represent the CDC Director on agencywide global health strategies and 

coordinate agency-wide policies and 

priorities focused on achieving 

maximum public health impact in 

support of the agency mission. CDC’s 

mission is to protect Americans from 


jspears on DSK121TN23PROD with NOTICES1